Psychiatry · Modesto, CA
NPI
1225111719
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
800 Scenic Dr
Modesto, CA, 95350
Phone (209) 558-4700
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$350K
950 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Manuel O Chua Jr. prescribed most often to Medicare patients was Olanzapine, with 128 prescriptions and refills. In total Manuel O Chua Jr. wrote 950 Medicare prescriptions that cost $350K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Olanzapine Generic | 128 | 128 | 15 | $6,242 |
| Divalproex Sodium Generic | 118 | 118 | Under 11 | $18K |
| Risperidone Generic | 91 | 91 | Under 11 | $3,567 |
| Clozapine Generic | 67 | 67 | Under 11 | $2,300 |
| Lithium Carbonate Generic | 48 | 48 | Under 11 | $671 |
| Ingrezza Valbenazine Tosylate | 39 | 39 | Under 11 | $142K |
| Divalproex Sodium Er Divalproex Sodium | 39 | 39 | Under 11 | $2,621 |
| Quetiapine Fumarate Er Quetiapine Fumarate | 37 | 37 | Under 11 | $22K |
| Clonazepam Generic | 35 | 35 | Under 11 | $672 |
| Trazodone Hcl Generic | 28 | 28 | Under 11 | $567 |
| Haloperidol Decanoate Generic | 27 | 27 | Under 11 | $1,440 |
| Donepezil Hcl Generic | 27 | 27 | Under 11 | $678 |
| Haloperidol Generic | 25 | 25 | Under 11 | $1,233 |
| Lybalvi Olanzapine/Samidorphan Malate | 24 | 24 | Under 11 | $46K |
| Quetiapine Fumarate Generic | 22 | 22 | Under 11 | $405 |
Brand drugs: 134 claims; generic drugs: 816 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Manuel O Chua Jr. were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.